Authors

Chen Han Yong

MBBS, Basic Physician Trainee, Division of Medicine, Lyell McEwin Hospital, Haydown Road, Elizabeth Vale, SA; Clinical Associate Lecturer, University of Adelaide, SA. Chenhan.yong108@gmail.com

Denosumab-related hypocalcaemia in chronic kidney disease

Pretreatment assessment and correction of serum calcium and vitamin D levels can reduce the risk of denosumab-related hypocalcaemia in chronic kidney disease.